PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:

• On September 7, 2022, Jan De Witte, chief executive officer will present at the Wells Fargo 2022 Healthcare Conference in Boston, MA at 8:35am ET.
• On September 12, 2022, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley Annual Global Healthcare Conference in New York, NY at 11:05am ET.

Webcast information can be found on the Company's website at Investor Relations.

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel^(TM), Aurora^(TM), Bactiseal^(TM), BioD^(TM), CerebroFlo^(TM), CereLink^(TM) Certas^(TM) Plus, Codman^(TM), CUSA^(TM), Cytal^(TM), DuraGen^(TM), DuraSeal^(TM), Gentrix^(TM), ICP Express^(TM), Integra^(TM), Licox^(TM) , MAYFIELD^(TM), MediHoney^(TM), MicroFrance^(TM), MicroMatrix^(TM), NeuraGen^(TM) , NeuraWrap^(TM) , PriMatrix^(TM), SurgiMend^(TM), TCC-EZ^(TM) and VersaTru^(TM). For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com